Immunother; 38: 127-134 14. Gjertsen MK, et al. , (1995) Vaccination with mutant ras peptides and induction of T- cell responsiveness in pancreatic car cinoma patients carrying the corresponding RAS mutation. The Lancet: 346: 1399-1400 15. Gjertsen M.K., Buanes T., Roseland A.R., Bakka A., Gladhaug I., Søreide O., Eriksen J.A., Møller M., Baksaas I., Lothe R.A., Sæterdal I., Gaudernack G. (2001) Intradermal RAS peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: clinical and immunological responses in patients with pancreatic adenocarcinoma. Int.